MAXMAT seeks funding to boost product development
This article was originally published in Clinica
Executive Summary
French company MAXMAT is looking for funds of around $2.5 million to accelerate the development, manufacturing and commercialisation of its Maxmat 130 automated analyser. The device, which is aimed at the smaller lab, combines clinical chemistry, immunology and coagulation functions.